Dr Han Chong Toh
is Senior Consultant and former Head at the Department of Medical Oncology and now Deputy Director, National Cancer Centre, Singapore. He graduated from the University of London, UK with an intercalated Bachelor of Science in ‘Infection and Immunity’ from St Mary’s Hospital Medical School and qualified as a medical doctor from University of Cambridge, UK. Dr Toh obtained his Fellowship of the Royal College of Physicians in 2003. He received his medical oncology fellowship training at the Singapore General Hospital, Massachusetts General Hospital, Harvard Medical School, Boston, USA and at the Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas, USA. He is also alumni at the Harvard Business School.
Dr Toh is a recipient of the National Clinician Scientist Award for his pioneering work in cell therapy for cancer and continues to work actively in the field of cell and immunogene therapy, the microenvironment and inflammation. He also had a strong interest in drug development for gastrointestinal cancers including colon and liver cancer.
Dr Toh is an Associate Professor and College Master at the Duke-NUS Graduate Medical School. He is also an adjunct Principal Investigator at the Institute of Molecular and Cell Biology, A*STAR. He has published over 75 peer review journal papers to date including in Nature Reviews Clinical Oncology, Nature Genetics, Lancet Oncology, Journal of Clinical Oncology, Journal of the National Cancer Institute, Cancer Research, Clinical Cancer Research, Molecular Therapy and Stem Cells.